The Hemostats market was valued at US$ 2,206.00 million in 2019 and it is projected to reach US$ 3,557.41 million by 2027; it is expected to grow at a CAGR of 6.3% from 2020 to 2027.
Hemostats play a basic and fundamental role during surgical procedures as it enables superior blood loss management. The products are has intraoperative and postoperative applications. Hemostats can be used for oozing venous type bleeds, diffusion of raw surface bleeding, bone bleeding, and needle-hole bleeding. The growth of the Hemostats market is attributed to the rising prevalence of chronic diseases, which are leading to increasing number of surgical procedures, number of strategic initiatives taken by governments, and growing number of hospitals. However, the growth of the market is expected to be restrained by lack of product awareness in emerging nations and lack of lucrative reimbursements.
The Hemostats market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Hemostats Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Applications of Hemostats in Healthcare to Drive Hemostats Market Growth
The increasing number of surgical procedures have also increased the use of hemostats. Increase in number of surgeries such as orthopedic surgeries for the replacements of knee & hip help to upsurge the market growth. The surgeries are done for the amputations of the limbs due to the injuries and damages caused by various diseases or road accidents. For instance, as per the U.S. Agency for Healthcare Research and Quality, approximately 600,000 knee replacement surgeries are performed per year in the United States.
Additionally, the number of surgeries is increasing due to the rising musculoskeletal disorders associated with sports, age-related dysfunction, and occupational injuries. For instance, as per the Arthritis Foundation, approximately 54 million adults had been diagnosed with arthritis in 2017. Moreover, nearly 300,000 babies and children have arthritis or a rheumatic condition.
The rising geriatric population can be a significant factor in increasing the number of surgical procedures. The knee replacement surgeries are being performed in the geriatric population for their deteriorating joints. As per the report, ‘Aging in the United States’ published by Population Reference Bureau’s revealed that the growing population (people 65 and older) are likely to reshape the scenario for the older population in America. The rise in conditions such as rheumatoid arthritis (RA), ankylosing spondylitis (AS), and osteoporosis in elderly age are driving the number of surgeries. For instance, as per the report published in 2018 of Healthline Media, rheumatoid arthritis (RA) affects 41 in every 100,000 people per year, and near round 1.3 million Americans have rheumatoid arthritis. Similarly, according to the International Osteoporosis Foundation (2018), osteoporosis is estimated to affect 200 million women across the world, among which near around one-tenth of women are above the age of 60, one-fifth of women aged more than 70, two-fifths of women aged above 80 and two-thirds of women aged more than 90. Thus, owing to the above mentioned factors, the market for hemostats is anticipated to grow in the forecast period.
The rise in the incidences of sports injuries is contributed by weekend sports players, professional athletes, youngsters, children playing in the societies, and sometimes adults. Most of the sports injuries are orthopedic injuries that include swelling, pain, strain, sprain, fractures, ligament breaks, and others. These injuries are broadly classified as acute and chronic types. The injuries or lesions are caused by sports such as water sports, water soccer (football), cricket, basketball, rugby, athletic games, and others. For instance, according to the Federation Internationale de Football Association (FIFA), the data has revealed that sports injuries are majorly caused by soccer.
Also, it is estimated that the ankle sprain is the most widely experienced injuries caused by football players worldwide. In the emergency department in the US, approx. 240,000 injuries were treated; among them, nearly 48,810 cases estimated for fractures, and about 79,400 cases were for sprains & strain, and also there were 5,000 cases for the dislocations.
Besides, as per the report published by BMJ Publishing Group Ltd (2017) stated that nearly 8% of the athletes incurred with one injury during the Olympic Games, in the Rio de Janeiro 2016 Olympic Summer Games. Also, according to the Stanford Children’s Health data published in 2018, in the United States, nearly 3.5 million children and teen has suffered from the injuries of the age group in between 14 years and below. It also reported that the highest rates of injuries occurred in sports involve contact and collisions. Severe injuries happened during individual sports and recreational activities. Additionally, approximately 62% of sports-related injuries occurred during the practice sessions.
Similarly, in cricket, the bowlers are more prone to get injured from the repetitive motion of their legs, elbow, and shoulders. The typical hams and injuries that are being observed are impingement syndromes, rotator cuff tears, ankle sprains, as well as medial ligament injuries to the elbow. Therefore, averagely 10% of the cricketers may suffer from lesions at any point in time in the field and approx. 15% of the incidences are contributed by the fast bowlers.
Moreover, according to the Stanford Children’s Health, some instances were given, which stated that near 170,000 children between the age group of 5 to 14years were treated for basketball-related injuries in hospital emergency rooms. Likewise, approximately 47,000 children were treated for in-line skating-related injuries. Similarly, around 65,000 children were treated for trampoline-related injuries in hospital emergency rooms.
After analyzing the facts and figures provided by the different organizations, it is expected that the market for the hemostats is likely to experience favorable growth in the forecast period.
Product-Based Insights
In terms of product, the Hemostats market is segmented into thrombin-based hemostats, combination hemostats, gelatin based hemostats, collagen based hemostats and oxidized regenerated cellulose based hemostats. In 2019, the thrombin based hemostats held the largest share of the market, by product.
Hemostats Market, by Product – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User-Based Insights
In terms of end user, the Hemostats market is segmented into hospitals & clinics and other end users. The hospitals and clinics held the largest share of end user segment in the global market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hemostats Market: Strategic Insights
Market Size Value in US$ 2,206.00 Million in 2019 Market Size Value by US$ 3,557.41 Million by 2027 Growth rate CAGR of 6.3% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hemostats Market: Strategic Insights
| Market Size Value in | US$ 2,206.00 Million in 2019 |
| Market Size Value by | US$ 3,557.41 Million by 2027 |
| Growth rate | CAGR of 6.3% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The Hemostats market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Hemostats Market – by Product
- Thrombin Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
Hemostats Market – by End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Other End Users
Hemostats Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- BD
- B. Braun Melsungen AG
- Baxter International Inc.
- Integra Life Sciences Corporation
- Teleflex Incorporated
- Johnson & Johnson Services, Inc.
- Biom'up
- ZMedica, LL
- Gelita Medical
- Pfizer Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; End User ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Hemostats refers to surgical supplies consisting of hemostatic agents and their delivering systems that are present in the form of pads, sponges, patches, powders, liquids or others. These hemostats are made from various blood clotting materials such as collagen, thrombin, cellulose, gelatin and others.
Rise in healthcare insurance providers, technological advancement and growing number of surgery procedures are projected to drive the growth of the global hemostats market during the forecast period. Moreover, growth of healthcare infrastructure among the untapped nations and increased initiatives taken up by governments are expected to fuel the growth of this market during the forecast period.
There are various types of hemostats available in the market priced within a range of US$ 5.0 to US$ 150.0 depending upon various factors such as formulation, material composition, application areas, quantity and others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Hemostats Market – By Product
1.3.2 Global Hemostats Market – By End User
1.3.3 Global Hemostats Market – By Geography
2. Global Hemostats Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hemostats – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe: PEST Analysis
4.2.3 APAC: PEST Analysis
4.2.4 MEA: PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Global Hemostats Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Increase in the Number of Surgical Procedures
5.1.2 Increasing Incidences of Sports Injuries
5.2 Key Market Restraints
5.2.1 Lack of Reimbursement
5.3 Key Market Opportunities
5.3.1 Growth in the Global Healthcare Market
5.4 Future Trends
5.4.1 Research Activities And Product Innovations
5.5 Impact Analysis
6. Hemostats Market – Global Analysis
6.1 Global Hemostats Market Revenue Forecast And Analysis
6.2 Global Hemostats Market, By Geography - Forecast And Analysis
6.3 Positioning of Key Players
7. Global Hemostats Market Analysis – by Product
7.1 Overview
7.2 Global Hemostats Market, by Product 2019 and 2027 (%)
7.3 Thrombin Based Hemostats
7.3.1 Overview
7.3.2 Thrombin Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
7.4 Combination Hemostats
7.4.1 Overview
7.4.2 Combination Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
7.5 Gelatin Based Hemostats
7.5.1 Overview
7.5.2 Gelatin Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
7.6 Collagen Based Hemostats
7.6.1 Overview
7.6.2 Collagen Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
7.7 Oxidized Regenerated Cellulose Based Hemostats
7.7.1 Overview
7.7.2 Oxidized Regenerated Cellulose Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
8. Hemostats Market Analysis – by End User
8.1 Overview
8.2 Hemostats Market, by End User 2019 and 2027 (%)
8.3 Hospitals and Clinics
8.3.1 Overview
8.3.2 Hospitals and Clinics Market, Revenue and Forecast to 2027 (US$ Mn)
8.4 Ambulatory Care Centers
8.4.1 Overview
8.4.2 Ambulatory Care Centers Market, Revenue and Forecast to 2027 (US$ Mn)
8.5 Others
8.5.1 Overview
8.5.2 Others Market, Revenue and Forecast to 2027 (US$ Mn)
9. Hemostats Market – Geographic Analysis
9.1 North America Hemostats Market Revenue and Forecasts to 2027
9.1.1 North America Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 North America Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.3 North America Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.4 North America Hemostats Market Revenue and Forecasts to 2027, By Country (%)
9.1.5 US Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.5.1 US Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.5.2 US Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.5.3 US Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.6 Canada Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 Canada Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 Canada Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.6.3 Canada Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.7 Mexico Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Mexico Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Mexico Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.7.3 Mexico Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.2 Europe Hemostats Market, Revenue and Forecast to 2027
9.2.1 Overview
9.2.2 Europe Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.3 Europe Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.4 Europe Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.5 Europe Hemostats Market, Revenue and Forecast to 2027, by Country (%)
9.2.6 Germany Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 Germany Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.6.2 Germany Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.6.3 Germany Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.7 UK Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 UK Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.7.2 UK Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.7.3 UK Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.8 France Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 France Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.8.2 France Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.8.3 France Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.9 Spain Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 Spain Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.9.2 Spain Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.9.3 Spain Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.10 Italy Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.1 Italy Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.10.2 Italy Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.10.3 Italy Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3 Asia Pacific Hemostats Market Revenue and Forecasts to 2027
9.3.1 Asia Pacific Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.2 Asia Pacific Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.3 Asia Pacific Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.1 Asia Pacific Hemostats Market Revenue and Forecasts to 2027, By Country (%)
9.3.2 Japan
9.3.2.1 Japan Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.2.2 Japan Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.3 China
9.3.3.1 China Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3.2 China Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.3.3 China Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.4 India
9.3.4.1 India Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.4.2 India Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.4.3 India Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.5 South Korea
9.3.5.1 South Korea Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.5.2 South Korea Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.5.3 South Korea Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.6 Australia
9.3.6.1 Australia Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.2 Australia Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.6.3 Australia Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027
9.4.1 Overview
9.4.2 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.3 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.4.4 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.5 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by Country (%)
9.4.6 Saudi Arabia
9.4.6.1 Saudi Arabia Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.6.2 Saudi Arabia Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.4.6.3 Saudi Arabia Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.7 UAE
9.4.7.1 UAE Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.7.2 UAE Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.4.7.3 UAE Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.8 South Africa
9.4.8.1 South Africa Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.8.2 South Africa Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.4.8.3 South Africa Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5 South And Central America Hemostats Market Revenue And Forecasts To 2027
9.5.1 South and Central America Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.2 South and Central America Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.5.3 South and Central America Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5.4 South and Central America Hemostats Market Revenue and Forecasts to 2027, By Country (%)
9.5.5 Brazil
9.5.5.1 Brazil Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.5.2 Brazil Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.5.5.3 Brazil Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5.6 Argentina
9.5.6.1 Argentina Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.2 Argentina Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.5.6.3 Argentina Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
10. Hemostats Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Hemostats Market, 2015-2019
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 BD
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 B. Braun Melsungen AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Baxter International Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Integra Life Sciences Corporation
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Teleflex Incorporated
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Johnson & Johnson Services, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Biom'up
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Z-Medica, LLC
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Gelita Medical
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Pfizer Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 2. North America Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 3. US Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 4. US Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 5. Canada Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 6. Canada Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 7. Mexico Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 8. Mexico Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 9. Europe Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 10. Europe Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 11. Germany Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 12. Germany Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 13. UK Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 14. UK Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 15. France Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 16. France Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 17. Spain Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 18. Spain Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 19. Italy Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 20. Italy Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 21. Asia Pacific Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 22. Asia Pacific Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 23. Japan Hemostats Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 24. Japan Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 25. China Hemostats Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 26. China Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 27. India Hemostats Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 28. India Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 30. South Korea Hemostats Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 31. South Korea Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 33. Australia Hemostats Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 34. Australia Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 35. Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 36. Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 37. Saudi Arabia Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 38. Saudi Arabia Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 39. UAE Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 40. UAE Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 41. South Africa Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
Table 42. South Africa Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
Table 43. South and Central America Hemostats Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 44. South and Central America Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 45. Brazil Hemostats Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 46. Brazil Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 47. Argentina Hemostats Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 48. Argentina Hemostats Market, Revenue and Forecast to 2027, By End User (US$ Mn)
Table 49. Recent Organic Growth Strategies in the Hemostats market
Table 50. Recent Inorganic Growth Strategies In The Hemostats Market
Table 51. Glossary of Terms, Hemostats Market
LIST OF FIGURES
Figure 1. Hemostats Market Segmentation
Figure 2. Hemostats Segmentation, by Region
Figure 3. Global Hemostats market, Revenue (US$ Mn), By Geography 2018 & 2027
Figure 4. Standalone Held Largest Share Of Component Segment In Hemostats Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Hemostats Market, By Geography (US$ Mn)
Figure 7. Global Hemostats Market- Leading Country Markets (US$ Mn)
Figure 8. Global Hemostats Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Hemostats Market in Europe: PEST Analysis
Figure 11. Hemostats Market In APAC: PEST Analysis
Figure 12. Hemostats Market in MEA: PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Hemostats Market Impact Analysis Of Driver And Restraints
Figure 15. Global Hemostats Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Hemostats Market – By Geography Forecast And Analysis – 2019- 2027
Figure 17. Prominent Players in the Hemostats Market
Figure 18. Global Hemostats Market, by Product 2019 and 2027 (%)
Figure 19. Thrombin Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 20. Combination Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 21. Gelatin Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 22. Collagen Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 23. Combination Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 24. Global Hemostats Market, by End User 2019 and 2027 (%)
Figure 25. Hospitals and Clinics Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 26. Ambulatory Care Centers Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 27. Others Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 28. North America Hemostats Market Revenue Overview, By Country, 2019 (US$ Mn)
Figure 29. North America Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America Hemostats Market Revenue and Forecasts to 2027, By Country (%)
Figure 31. Product Analysis (US Market)
Figure 32. US Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Canada Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Mexico Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Europe Hemostats Market, Revenue by Country (2019) (US$ Mn)
Figure 36. Europe Hemostats Market Revenue and Forecast to 2027 (US$ Mn)
Figure 37. Europe Hemostats Market, Revenue and Forecast to 2027, by Country (%)
Figure 38. Germany Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 39. UK Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 40. France Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 41. Spain Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 42. Italy Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 1. Asia Pacific Hemostats Market Revenue Overview, by Country, 2019 (US$ MN)
Figure 2. Asia Pacific Hemostats Market Revenue and Forecast to 2027 (US$ Mn)
Figure 3. Asia Pacific Hemostats Market Revenue and Forecasts to 2027, By Country (%)
Figure 4. Japan Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 5. China Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 6. India Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 7. South Korea Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 8. Australia Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 9. Middle East & Africa Hemostats Market, Revenue by Country, 2019 (US$ Mn)
Figure 10. Middle East & Africa Hemostats Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11. Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by Country (%)
Figure 12. Saudi Arabia Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 13. UAE Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 14. South Africa Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 15. South and Central America Hemostats Market Revenue Overview, by Country, 2019 (US$ MN)
Figure 16. South and Central America Hemostats Market Revenue and Forecast to 2027 (US$ Mn)
Figure 17. South and Central America Hemostats Market Revenue and Forecasts to 2027, By Country (%)
Figure 18. Brazil Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Argentina Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Growth Strategies In The Hemostats Market, 2015-2019
The List of Companies - Hemostats Market
- Johnson & Johnson Services, Inc. (Ethicon LLC)
- BD
- Baxter
- B. Braun Melsungen Ag
- Pfizer, Inc.
- GELITA MEDICAL
- Integra Lifesciences Holdings Corporation
- Z-Medica, LLC
- Biom’up
- Teleflex Incorporated
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Hemostats Market
Feb 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Feb 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Feb 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)